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What is Diabetic
Retinopathy




Diabetic retinopathy is a disease that causes damage to
the eyes as a result of chronic hyperglycemia. The
disease is categorized into two types:


Proliferative diabetic retinopathy involves the
pathologic proliferation of blood vessels in the eye
which can cause preretinal and vitreous
hemorrhage, fibrosis and retinal detachment



Nonproliferative diabetic retinopathy involves
nerve-fiber infarcts, which cause cotton wool
spots, microvascular abnormalities, and hard
exudates

Macular edema, defined by retinal thickening and
swelling of the macula, can happen at any point in
disease and also leads to vision loss1

The Problem:


Diabetic retinopathy is the leading cause of blindness in people age 25-74 in the
world 1



It has an insidious onset, and when patient’s become symptomatic, it’s often too
late to intervene



On average only 60% of diabetic patient’s receive an annual eye exam and in
underserved areas that can drop to 25% 2



2% of patient’s with existing diabetic retinopathy with progress to blindness every
year 3



The prevalence of vision loss from diabetes has risen by nearly 2/3 in the past 2
decades, in 2010 833,690 people were blind as a result of DR and 3.7 million were
visually impaired 4



In the Western Connecticut Health Network (WCHN) only 32% of diabetic patient’s
have had a documented eye exam in the past year. 3

Economics


Annual total cost of blindness per person is
estimated to be $18,670 5



Annual direct cost of eye related care for a
blind patient is approximately $4443 6



Total annual medical expenditure related to
blindness in USA is $8,102,000,000 7



The cost of a community based diabetic
screening is approximately $116 8



The cost of diabetic retinopathy referral was
$478 (24.4% of patients referred with diabetic
retinopathy) 8

Community Perspective




Dr. Ferreira of Brookfield Family Medicine (part of WCHN) had this to say:


“Historically our practice has not referred patients for diabetic eye exams. We’ve always
educated patient’s about the importance of the exam and told them to see the eye doctor
on their own. Unfortunately there is no way to verify if they went or not.”



This will change in January when his practice begins a new telemedicine screening
program in which patients can get their screening done in the office using IRIS teleretinal
technology. During this 5 minute exam the machine takes a detailed image of the patient’s
retina and sends it to Ophthalmologists at the Mayo Clinic for analysis. Should signs of
diabetic retinopathy be found, patients are then referred to ophthalmology.



Dr. Ferriera believes that the key to this screening program’s success will be educating
patient’s about the dangers of diabetic retinopathy and the importance of screening.

A Danbury CT Ophthalmologist commented that she believed doctors in her
community were doing very well with referring patient’s for diabetic eye exams. She
felt that the biggest barrier to care was lack of health insurance in patients under
65. She was enthusiastic about the new telemedicine screening at Brookfield Family
Medicine, but cautioned that this screening was only part of the care necessary, and
that in person screening for retinopathy is always superior.

Intelligent Retinal Imaging
System (IRIS) Machine

Intervention and Methodology


A patient handout was created to educate patient’s about
diabetic retinopathy



This handout emphasized the prevalence of diabetic
retinopathy, the insidious onset of the disease and the
importance of screening



The handout also included details about the new
telemedicine screening program at Brookfield Family
Medicine, encouraging patients to learn more about and
consider participating in the screening

Results


The patient education pamphlet was distributed to a few patients and
preliminary responses included:


“This is very good…I knew eye exams were important, but I never realized why
before…I’m going to the eye doctor now…My daughter needs to know about this…”



Ideally this pamphlet will both serve to educate patients who were unaware
of the dangers of diabetic retinopathy and encourage those already aware to
get their annual screening



The long term goal of this pamphlet is to inform and encourage patients to
take advantage of the new, convenient and inexpensive primary care based
diabetic retinopathy screening program at Brookfield Family Medicine

Limitations


This intervention was done in only one family medicine practice, so it was
impossible to assess the effectiveness across a more diverse patient
population



Additionally given time constraints, only a few patients were able to see the
pamphlets and provide feedback



Furthermore longitudinal follow up to assess patient compliance with
screening was also not possible given time constraints

Future Directions


A quality control study could be conducted in a longitudinal manner to assess
whether patients were more inclined to get diabetic retinopathy screening
after viewing the pamphlet



This pamphlet could be made available in all 16 Western Connecticut Medical
Group primary care practices, thus dramatically increasing its impact and
potential sample size



Further study opportunities are available with the advent of the primary care
based teleretinal screening program in January

References
1.

Fraser CE, et al. “Diabetic retinopathy: Classification and Clinical features.” Post TW, ed. UpToDate.
Waltham, MA: UpToDate Inc. http://www.uptodate.com. Accessed on Nov 02, 2018.

2.

Daskivich LP, et al. “Implementation and Evaluation of a Large-Scale Teleretinal Diabetic Retinopathy
Screening Program in the Los Angeles County Department of Health Services.” JAMA Internal Medicine, vol.
177, no. 5, 2017, p. 642., doi:10.1001/jamainternmed.2017.0204.

3.

Ferreira, C. Personal interview. Nov 14, 2018.

4.

Leasher JL, et al. “Erratum. Global Estimates on the Number of People Blind or Visually Impaired by Diabetic
Retinopathy: A Meta-Analysis From 1990–2010. Diabetes Care 2016;39:1643–1649.” Diabetes Care, vol. 39, no.
11, 2016, pp. 2096–2096., doi:10.2337/dc16-er11.

5.

Bramley T. “Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries With Glaucoma.” Archives
of Ophthalmology, vol. 126, no. 6, 2008, p. 849., doi:10.1001/archopht.126.6.849.

6.

Javitt JC, et al. “Association between Vision Loss and Higher Medical Care Costs in Medicare
Beneficiaries.” Ophthalmology, vol. 114, no. 2, 2007, doi:10.1016/j.ophtha.2006.07.054.

7.

Frick KD, et al. “Economic impact of visual impairment and blindness in the United States.” Arch Ophthalmol.
2007 Apr;125(4):544-50.

8.

Byrne MM, et al. “Cost of a Community-Based Diabetic Retinopathy Screening Program.” Diabetes Care, vol.
37, no. 11, 2014, doi:10.2337/dc14-0834.

9.

Hendrick AM, et al. “Diabetic Retinopathy.” Prim Care. 2015 Sep;42(3):451-64. doi:
10.1016/j.pop.2015.05.005.

10.

Rosenberg JB, Tsui I. “Screening for Diabetic Retinopathy.” N Engl J Med. 2017 Apr 20;376(16):1587-1588. doi:
10.1056/NEJMe1701820.

11.

Nathan DM, et al. “Frequency of Evidence-Based Screening for Diabetic Retinopathy.” N Engl J Med. 2017 Jul
13;377(2):195. doi: 10.1056/NEJMc1706322.

